Encora X1 in Daily Life for Essential Tremor
Official title: The Encora X1™ in a Real World Observational Study
Run by Encora, Inc. · NCT07911488 · Data updated 2026-11-12
This real-world study tests how the Encora X1 wrist device affects day-to-day activities for adults with essential tremor over three years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Encora, Inc. Industry-sponsored |
| Locations | 1 site (Boston, Massachusetts) |
| Status | Recruiting |
| Started | November 1, 2026 |
| Main results expected | November 2031 |
| Study ends | August 2032 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07911488 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older with upper limb essential tremor who have a prescription for the Encora X1 and can participate online.
✕Probably not a fit
Individuals with active skin conditions at the stimulation site or other contraindicated conditions may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows users of the Encora X1 neurostimulator in a home setting to observe long-term use and satisfaction. Participants are adults with essential tremor who have a prescription for the device and can complete online questionnaires. The study collects information on daily functioning and user experience over up to 36 months without changing the device’s use. It aims to understand real-world patterns, convenience, and potential benefits outside a controlled clinical environment.
Why it matters
Potential benefit: If successful, the study could show how the Encora X1 helps people manage daily activities and improve overall quality of life.
How similar studies have gone: Previous real-world observations of similar non-invasive tremor devices have reported improvements in daily functioning for some users, though results vary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 years or older and able to comply with all study procedures * A diagnosis of upper limb Essential Tremor (ET) as determined by clinical history * A prescription for the Encora X1™ * Must have at least occasional access to a computer, tablet or smartphone, and be able to complete study questionnaires through the participant portal. * Mentally competent to understand and able to perform written, informed consent (in English only) to participate in the study Exclusion Criteria: * Swollen, infected, inflamed areas, or skin eruptions, open wounds, or cancerous lesions of skin at stimulation site * History of psoriasis, eczema or atopic dermatitis at the stimulation site * History of peripheral neuropathy in the upper limbs, including carpal tunnel syndrome and diabetic neuropathy * Pregnant women, or women who plan to become pregnant during their duration of the study * Use of other External Upper Limb Tremor Stimulation Therapy during the course of the study * Patient unable to communicate with sponsor/investigator and study staff * Any other medical conditions or physical or mental impairments that in the sponsor/investigator's opinion would render the participant unsuitable as a candidate for the study.
Where it's running
-
Encora Therapeutics
Boston, Massachusetts, United States Recruiting
Study contacts
- Principal investigator: Ann Marie Murray, MD — West Virginia University
- Study coordinator: Alexis Noyes
- Email: advocates@encoratherapeutics.com
- Phone: 413-529-6728
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment
This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.
-
Microelectrode-based brain stimulation for Parkinson’s and essential tremor
This early feasibility test checks a new microelectrode-based brain stimulation method in adults with Parkinson’s disease or essential tremor who are already getting deep brain stimulation implants.
-
Non-Invasive Nerve Stimulation for Essential Tremor: Long-Term Safety and Effectiveness
This study tests whether a non-invasive stimulation device called TAPS helps reduce tremor in adults with essential tremor over a long period.
-
Low Intensity Focused Ultrasound for Essential Tremor in Adults
This early-stage, open-label study tests whether repeated low-intensity focused ultrasound can safely and briefly modulate tremor in people with essential tremor.
-
Closed-loop TMS to reduce tremor
This trial tries phase-locked transcranial magnetic stimulation (TMS) to reduce tremor in people with essential tremor or Parkinson's disease.
-
How deep brain stimulation affects learning and producing speech in Parkinson's disease and essential tremor
This research will see if turning deep brain stimulation on and off changes how adults with Parkinson's disease or essential tremor learn and produce new speech sound sequences.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.